An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease

Human Genetics

Volumn 120, Issue 2, 2006, Pages 201-210

  Wetmore, James B ^a,c   Johansen, Kirsten L ^a   Sen, Saunak ^b   Hung, Adriana M ^a,d   Lovett, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; DIPEPTIDYL CARBOXYPEPTIDASE; THYMINE;

ADULT; AGE; ALGORITHM; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENDER; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RACE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

AGED; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 33747000019     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-006-0191-4     Document Type: Article

References (45)

1. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A (2000) ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20:484-492
2. Akaike H (1973) Information theory and an extension of the maximum likelihood principle. In: Csaki F (ed) Proceedings of the second international symposium on information theory, Akademiai Kiado, Budapest, pp 267-281
3. Bakris GL (2001) Angiotensin-converting enzyme inhibition to enhance vascular health-clinical and research models. Am J Hypertens 14:264S-269S
4. Bouzekri N, Zhu X, Jiang Y, McKenzie CA, Luke A, Forrester T, Adeyemo A, Kan D, Farrall M, Anderson S, Cooper RS, Ward R (2004) Angiotensin I-converting enzyme polymorphisms, ACE level and blood pressure among Nigerians, Jamaicans and African-Americans. Eur J Hum Genet 12:460-468
5. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
6. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, et al (1994) Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90:669-676
7. Chiano MN, Clayton DG (1998) Fine genetic mapping using haplotype analysis and the missing data problem. Ann Hum Genet 62(Pt 1):55-60
8. Cooper ME (2004) The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Am J Hypertens 17:16S-20S; quiz A2-A4
9. Cox DR, Hinkley DV (1974) Theoretical statistics. Chapman and Hall, New York
10. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M, Cooper R, Adeyemo A, Soubrier F, Ward R, Lathrop GM, Matsuda F, Farrall M (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 11:2969-2977
11. Dzau VJ (1993) Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 153:937-942
12. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, Van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, Weber M (2002) Pathophysiologic and therapeutic importance of tissue ACE: A consensus report. Cardiovasc Drugs Ther 16:149-160
13. Emigh TH (1980) Comparison of tests for Hardy-Weinberg equilibrium. Biometrics 36:627-642
14. Erdos EG, Skidgel RA (1987) The angiotensin I-converting enzyme. Lab Invest 56:345-348
15. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927
16. Foy CA, Rice GI, Ossei-Gerning N, Mansfield MW, Grant PJ (1997) Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 100:420-425
17. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W (1995) Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 92:2796-2799
18. Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:512-526
19. Progress Collaborative Group (2001) Randomised trial of a perindopril-based blood- pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033-1041
20. Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M (2003) The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 42:297-303
21. Jaffe IZ, Mendelsohn ME (2005) Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 96:643-650
22. Johnston CI (1994) Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23:258-268
23. Karagiannis A, Balaska K, Tziomalos K, Tokalaki-Nikolaidou L, Papayeoryiou A, Zamboulis C (2004) Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke. Eur Neurol 51:148-152
24. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E, Lathrop M, Farrall M (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745-1751 1745-1751
25. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA (2003) Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 12:859-867
26. Kehoe PG, Katzov H, Andreasen N, Gatz M, Wilcock GK, Cairns NJ, Palmgren J, de Faire U, Brookes AJ, Pedersen NL, Blennow K, Prince JA (2004) Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. Hum Genet 114:478-483
27. Kjeldsen SE, Julius S (2004) Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Am Heart J 148:747-754
28. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL (1999) Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 84:1043-1049
29. Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S (2002) Risk of new-onset diabetes in the Losartan intervention for endpoint reduction in hypertension study. J Hypertens 20:1879-1886
30. Nadar S, Blann AD, Lip GY (2004) Antihypertensive therapy and endothelial function. Curr Pharm Des 10:3607-3614
31. Okuno S, Utsugi T, Ohno T, Ohyama Y, Uchiyama T, Tomono S, Kurabayashi M (2003) Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: A 9-year follow-up study. J Int Med Res 31:290-298
32. Pei YP, Greenwood CM, Chery AL, Wu GG (2000) Racial differences in survival of patients on dialysis. Kidney Int 58:1293-1299
33. Price DA, Owen WF Jr (1997) African-Americans on maintenance dialysis: A review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther 4:3-12
34. Pueyo ME, Challah M, Gauguier D, Louedec L, Philippe M, Gaertner R, Marre M, Michel JB, Jacob MP (2004) Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: A possible link between ACE genotype and diabetic nephropathy. Diabetes 53:1111-1118
35. Rieder MJ, Taylor SL, Clark AG, Nickerson DA (1999) Sequence variation in the human angiotensin converting enzyme. Nat Genet 22:59-62
36. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL (1996) A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94:708-712
37. Sokol SI, Portnay EL, Curtis JP, Nelson MA, Hebert PR, Setaro JF, Foody JM (2004) Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke. Neurology 63:208-213
38. Soubrier F, Martin S, Alonso A, Visvikis S, Tiret L, Matsuda F, Lathrop GM, Farrall M (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 10:553-561
39. Struthers AD (2004) Aldosterone blockade in cardiovascular disease. Heart 90:1229-1234
40. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC (2003) Peripheral vascular disease in Type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 20:988-995
41. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F (1996) Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 58:1268-1278
42. Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Verho M, Gross W, Marz W (1996) Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 125:19-25
43. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder MJ (2000) Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 67:1144-1153
44. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R (2001) Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 68:1139-1148
45. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A, Chakravarti A (2003) Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: Findings from the family blood pressure program. Genome Res 13:173-181